Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Evaluate Mavacamten in Adolescents With Symptomatic Obstructive Hypertrophic Cardiomyopathy
Sponsor: Bristol-Myers Squibb
Summary
The purpose of this study is to evaluate the efficacy, safety, and pharmacokinetics of mavacamten in adolescent patients with symptomatic obstructive hypertrophic cardiomyopathy (HCM).
Official title: A Randomized, Double-blind, Placebo-controlled Clinical Study to Evaluate Mavacamten in Adolescents (Age 12 Years to < 18 Years) With Symptomatic Obstructive Hypertrophic Cardiomyopathy
Key Details
Gender
All
Age Range
12 Years - 17 Years
Study Type
INTERVENTIONAL
Enrollment
44
Start Date
2024-04-17
Completion Date
2031-03-28
Last Updated
2025-12-19
Healthy Volunteers
No
Conditions
Interventions
Mavacamten
Specified dose on specified days
Placebo
Specified dose on specified days
Locations (47)
Local Institution - 0017
Birmingham, Alabama, United States
Local Institution - 0050
Phoenix, Arizona, United States
Local Institution - 0032
Los Angeles, California, United States
Local Institution - 0008
Los Angeles, California, United States
Local Institution - 0033
Palo Alto, California, United States
Local Institution - 0044
San Diego, California, United States
Local Institution - 0038
Aurora, Colorado, United States
Local Institution - 0031
St. Petersburg, Florida, United States
Local Institution - 0053
Atlanta, Georgia, United States
Local Institution - 0013
Chicago, Illinois, United States
Local Institution - 0009
Indianapolis, Indiana, United States
Local Institution - 0043
Boston, Massachusetts, United States
Local Institution - 0002
Ann Arbor, Michigan, United States
Local Institution - 0037
St Louis, Missouri, United States
Local Institution - 0052
Morristown, New Jersey, United States
Local Institution - 0010
New Hyde Park, New York, United States
Local Institution - 0024
New York, New York, United States
Local Institution - 0036
New York, New York, United States
Local Institution - 0040
The Bronx, New York, United States
Local Institution - 0015
Charlotte, North Carolina, United States
Local Institution - 0039
Durham, North Carolina, United States
Local Institution - 0019
Cincinnati, Ohio, United States
Local Institution - 0001
Cleveland, Ohio, United States
Local Institution - 0029
Columbus, Ohio, United States
Local Institution - 0030
Philadelphia, Pennsylvania, United States
Local Institution - 0005
Pittsburgh, Pennsylvania, United States
Local Institution - 0034
Memphis, Tennessee, United States
Local Institution - 0045
Austin, Texas, United States
Local Institution - 0054
Houston, Texas, United States
Local Institution - 0003
Salt Lake City, Utah, United States
Local Institution - 0012
Charlottesville, Virginia, United States
Local Institution - 0020
Sydney, New South Wales, Australia
Local Institution - 0042
Clayton, Victoria, Australia
Local Institution - 0041
Edmonton, Alberta, Canada
Local Institution - 0046
Toronto, Ontario, Canada
Local Institution - 0022
Paris, France
Local Institution - 0026
Pessac, France
Local Institution - 0006
Munich, Bavaria, Germany
Local Institution - 0018
Berlin, State of Berlin, Germany
Local Institution - 0047
Dublin 12, D12 N512, Ireland
Local Institution - 0016
Florence, FI, Italy
Local Institution - 0051
Genova, GE, Italy
Local Institution - 0027
Naples, Italy
Local Institution - 0014
Barcelona, B, Spain
Local Institution - 0025
Madrid, Spain
Local Institution - 0049
Belfast, BFS, United Kingdom
Local Institution - 0007
London, United Kingdom